Search
-
News
Meet Sashi Ghosal, an IT project manager at MSK. He has always benefited from doting relatives, kind bosses, and caring colleagues who have offered him support, counsel, or career advice that has transformed his life.
… Friday, May 21, 2021 Sashi Ghosal is grateful. He has always benefited from doting relatives, kind bosses, and caring colleagues who have offered him support, counsel, or career advice that has transformed his life — and led him, eventually, to Memorial Sloan Kettering, where he works as an IT Project
-
News
MSK now offers interventional radiology consultations as well as many procedures at three of its outpatient locations.
… Thursday, January 12, 2017 Summary Memorial Sloan Kettering is making interventional radiology consultations as well as many procedures available to patients receiving treatment at our locations in Westchester , New York; Commack, Long Island; and Monmouth , New Jersey. Highlights Interventional radiology
-
News
An internationally recognized surgeon-scientist, Dr. Drebin has been named 2024 President-Elect of the American Surgical Association.
… Monday, April 8, 2024 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that Jeffrey A. Drebin, MD, PhD , has been named President-Elect of the American Surgical Association (ASA) for 2024. An internationally recognized surgeon-scientist and the Chair of MSK’s Department of Surgery,
-
News
Learn about research at MSK that finds obesity can influence driver mutations that produce specific subtypes of cancers, including lung and endometrial cancers.
… Monday, October 28, 2024 Obesity or being overweight can increase your risk of developing cancer . It can lead to chronic inflammation and hormonal changes, which can damage DNA and cause uncontrolled cell growth. Now new research at Memorial Sloan Kettering Cancer Center (MSK) suggests obesity may
-
News
In a first-of-its-kind collaboration, MSK has joined forces with the Chinese Thoracic Oncology Group in an effort to establish a program of clinical trials that are open to patients from both the United States and China.
… Friday, April 19, 2019 In a first-of-its-kind collaboration, Memorial Sloan Kettering has joined forces with the Chinese Thoracic Oncology Group (CTONG) — an alliance of more than 20 premier academic cancer centers in China — in an effort to establish a program of clinical trials that are open to patients
-
News
在史上首次该类型合作中,MSK 与中国胸部肿瘤研究协作组将携手共进,共同打造一个对来自美国和中国的患者都开放的临床试验项目。
… Friday, April 19, 2019 中国胸部肿瘤研究协作组 (CTONG) 是由 20 多个中国顶尖学术癌症中心组成的联盟。Memorial Sloan Kettering 首次与 CTONG 合作,努力促成一项对中美两国患者开放的临床试验项目。 该举措将重点关注 肺癌 精准治疗的临床试验。在中美两国,肺癌都是癌症致死的头号杀手。 此次合作于去年 12 月正式启动,旨在为中美两国的多中心 临床试验 奠定学术基础,最终目标是提高临床试验参与率,推动有效的新疗法尽快获批。 合作期间还实施了其他显著措施,包括远程医疗和教育举措,旨在改善两国患者的护理状况,并努力推动行业参与。 为获得该领域的指导
-
News
While we stay home to flatten the curve of COVID-19, hardworking healthcare professionals are putting in long hours on the front lines.
… Thursday, April 23, 2020 While we stay home to flatten the curve of COVID-19, hardworking healthcare professionals are putting in long hours on the front lines. Memorial Sloan Kettering Cancer Center (MSK) is encouraging our healthcare heroes to take a moment to recharge during this challenging time.
-
News
With the help of machine learning, computational biologists are learning to predict how cancers will evolve.
… Wednesday, June 23, 2021 From amoebas to zebras, all living things evolve. They change over time as pressures from the environment cause individuals with certain traits to become more common in a population while those with other traits become less common. Cancer is no different. Within a growing tumor
-
News
Learn about gastrointestinal distress, one of the more common side effects of immunotherapy.
… Thursday, January 31, 2019 Summary One of the most common immunotherapy side effects is gastrointestinal distress. MSK gastroenterologist David Faleck explains why this happens and how to find relief. Chances are that you have heard some buzz about immunotherapy . This type of cancer treatment trains
-
News
Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that Michel Sadelain, MD, PhD, renowned physician-scientist, Director of the Center for Cell Engineering, and Stephen and Barbara Friedman Chair, has been awarded the 2024 Breakthrough Prize in Life Sciences.
… Thursday, September 14, 2023 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that Michel Sadelain, MD, PhD, renowned physician-scientist, Director of the Center for Cell Engineering, and Stephen and Barbara Friedman Chair, has been awarded the 2024 Breakthrough Prize in Life Sciences